BioSpace News Archive

The 2nd International Intelligent Medical and Intellectual Property Summit & ICI Annual Meeting Was Held Successfully

During May 30-31, the 2nd International Intelligent Medical and Intellectual Property Summit & ICI Annual Meeting were held in the Zhongguancun Dongsheng Science and Technology Park.

June 3, 2019
·
2 min read
Drug Development

4D Presents MRx0518 Combination Study at ASCO 2019, Chicago, USA

4D pharma plc announces the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined with KEYTRUDA® in patients with solid tumours who have failed prior anti-PD-1 therapy at the 55th Annual Meeting of the American Society of Clinical Oncology in Chicago, USA.

June 3, 2019
·
3 min read
Drug Development

BioInvent Submits IND for Phase I/IIa Trial of Anti-FcγRIIB Antibody

BioInvent International AB announces the submission to the U.S. Food and Drug Administration of an Investigational New Drug application for a Phase I/IIa clinical trial of an immune-modulatory anti-FcγRllB antibody in combination with an anti-PD1 antibody in solid tumors.

June 3, 2019
·
3 min read
Business

LEO Pharma appoints Catherine Mazzacco as new CEO

LEO Pharma, a global leader in medical dermatology, announced that Gitte Aabo will step down as President and CEO after 27 years in the company, 11 of these as CEO.

June 3, 2019
·
2 min read
Biotech Bay

Intabio to Present Groundbreaking Innovation in Therapeutic Antibody Quality Characterization at ASMS Conference

Intabio, Inc. announced it will present a powerful new approach to biotherapeutic quality characterization at June’s ASMS Conference in Atlanta, GA - the world’s first fully-integrated imaged capillary isoelectric focusing–mass spectrometry assay.

June 3, 2019
·
2 min read
Business

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials

Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons.

June 3, 2019
·
4 min read
Policy

Viriom Files for Market Authorization in China

Iain Dukes, CEO of Viriom Inc, presented Viriom’s strategy on high growth developing markets, which includes obtaining a market authorization in China, at the 11th ChinaBio Annual International Partnering Conference in Shanghai.

June 3, 2019
·
1 min read
Drug Development

Xencor Doses First Patient in Phase 1 Study of XmAb®22841 for the Treatment of Patients with Advanced Solid Tumors

XmAb22841, a CTLA-4 x LAG-3 bispecific antibody, is Xencor’s third tumor microenvironment (TME) activator to enter clinical development

June 3, 2019
·
4 min read
Policy

BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by Patents Granted in Korea

“Compositions and Methods for Prediction of Drug Sensitivity, Resistance, and Disease Progression” (KR10-1977875) for PathMAP® Functional Signaling Profile technology

June 3, 2019
·
5 min read
Genetown

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

Company showcasing new product and application expansions at ASMS conference

June 3, 2019
·
3 min read